These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30919253)

  • 1. Long-term performance of risk scores for venous thromboembolism in ambulatory cancer patients.
    Di Nisio M; van Es N; Rotunno L; Anzoletti N; Falcone L; De Tursi M; Natoli C; Tinari N; Cavallo I; Valeriani E; Candeloro M; Guglielmi MD; Rutjes AWS; Porreca E
    J Thromb Thrombolysis; 2019 Jul; 48(1):125-133. PubMed ID: 30919253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison among three predictive models for cancer-associated thromboembolism in a hispanic population.
    Ramos-Esquivel A; Marenco-Flores A; Hernández-Romero G; Céspedes-Calvo A; Mora-Hidalgo R
    J Thromb Thrombolysis; 2023 Oct; 56(3):433-438. PubMed ID: 37407771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the ONKOTEV Risk Prediction Model for Venous Thromboembolism in Outpatients With Cancer.
    Cella CA; Knoedler M; Hall M; Arcopinto M; Bagnardi V; Gervaso L; Pellicori S; Spada F; Zampino MG; Ravenda PS; Frassoni S; Passaro A; Milano M; Laffi A; Fazio N; Lordick F
    JAMA Netw Open; 2023 Feb; 6(2):e230010. PubMed ID: 36795409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Khorana vs. ONKOTEV predictive score to individualize anticoagulant prophylaxis in outpatients with cancer.
    Cella CA; Djulbegovic B; Hozo I; Lordick F; Bagnardi V; Frassoni S; Gervaso L; Fazio N
    Eur J Cancer; 2024 Sep; 209():114234. PubMed ID: 39142210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study.
    van Es N; Di Nisio M; Cesarman G; Kleinjan A; Otten HM; Mahé I; Wilts IT; Twint DC; Porreca E; Arrieta O; Stépanian A; Smit K; De Tursi M; Bleker SM; Bossuyt PM; Nieuwland R; Kamphuisen PW; Büller HR
    Haematologica; 2017 Sep; 102(9):1494-1501. PubMed ID: 28550192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of risk factors and assessment models for predicting venous thromboembolism in lung cancer patients.
    Rupa-Matysek J; Lembicz M; Rogowska EK; Gil L; Komarnicki M; Batura-Gabryel H
    Med Oncol; 2018 Apr; 35(5):63. PubMed ID: 29616356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Khorana, PROTECHT, and 5-SNP scores for prediction of venous thromboembolism in patients with cancer.
    Guman NAM; van Geffen RJ; Mulder FI; van Haaps TF; Hovsepjan V; Labots M; Cirkel GA; Y F L de Vos F; Ten Tije AJ; Beerepoot LV; Tjan-Heijnen VCG; van Laarhoven HWM; Hamberg P; Vulink AJE; Los M; Zwinderman AH; Ferwerda B; Lolkema MPJK; Steeghs N; Büller HR; Kamphuisen PW; van Es N
    J Thromb Haemost; 2021 Dec; 19(12):2974-2983. PubMed ID: 34409743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence, outcome and risk stratification tools for venous thromboembolism in advanced pancreatic cancer - A retrospective cohort study.
    Kruger S; Haas M; Burkl C; Goehring P; Kleespies A; Roeder F; Gallmeier E; Ormanns S; Westphalen CB; Heinemann V; Rank A; Boeck S
    Thromb Res; 2017 Sep; 157():9-15. PubMed ID: 28675831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventing Venous Thromboembolism in Ambulatory Cancer Patients: The ONKOTEV Study.
    Cella CA; Di Minno G; Carlomagno C; Arcopinto M; Cerbone AM; Matano E; Tufano A; Lordick F; De Simone B; Muehlberg KS; Bruzzese D; Attademo L; Arturo C; Sodano M; Moretto R; La Fata E; De Placido S
    Oncologist; 2017 May; 22(5):601-608. PubMed ID: 28424324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal authoritative risk assessment score of Cancer-associated venous thromboembolism for hospitalized medical patients with lung Cancer.
    Xiong W; Zhao Y; Du H; Wang Y; Xu M; Guo X
    Thromb J; 2021 Dec; 19(1):95. PubMed ID: 34863189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of risk prediction scores for cancer-associated thrombosis in ambulatory cancer patients not receiving thromboprophylaxis: A prospective cohort study in a South-East Asian population.
    Thipbumrung S; Niprapan P; Suprasert P; Ketpueak T; Tantiworawit A; Punnachet T; Hantrakun N; Piriyakhuntorn P; Rattanathammethee T; Hantrakool S; Rattarittamrong E; Norasetthada L; Chai-Adisaksopha C
    Thromb Res; 2023 Dec; 232():138-144. PubMed ID: 37979462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Biomarkers for the Prediction of Venous Thromboembolism in Ambulatory Cancer Patients.
    Schorling RM; Pfrepper C; Golombek T; Cella CA; Muñoz-Unceta N; Siegemund R; Engel C; Petros S; Lordick F; Knödler M
    Oncol Res Treat; 2020; 43(9):414-427. PubMed ID: 32580190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ONKOTEV Score as a Predictive Tool for Thromboembolic Events in Pancreatic Cancer-A Retrospective Analysis.
    Godinho J; Casa-Nova M; Moreira-Pinto J; Simões P; Paralta Branco F; Leal-Costa L; Faria A; Lopes F; Teixeira JA; Passos-Coelho JL
    Oncologist; 2020 Feb; 25(2):e284-e290. PubMed ID: 32043787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Models for predicting venous thromboembolism in ambulatory patients with lung cancer: A systematic review and meta-analysis.
    Yan AR; Samarawickrema I; Naunton M; Peterson GM; Yip D; Newman P; Mortazavi R
    Thromb Res; 2024 Feb; 234():120-133. PubMed ID: 38215613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating Venous Thromboembolism Risk in Metastatic Colorectal Cancer Inpatients: Validation of Existing Risk Scores and Development of New Risk Scores.
    Qin L; Liang Z; Xie J; Li X
    Clin Appl Thromb Hemost; 2023; 29():10760296231196859. PubMed ID: 37691565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External Validation of Risk Scores for Predicting Venous Thromboembolism in Ambulatory Patients with Lung Cancer.
    Yan AR; Yip D; Peterson GM; Samarawickrema I; Naunton M; Newman P; Mortazavi R
    Cancers (Basel); 2024 Sep; 16(18):. PubMed ID: 39335138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Khorana Score in Predicting Venous Thromboembolism for Patients With Metastatic Urothelial Carcinoma and Variant Histology Treated With Chemotherapy.
    Ramos JD; Casey MF; Bamias A; De Giorgi U; Bellmunt J; Harshman LC; Ladoire S; Wong YN; Alva AS; Rosenberg JE; Galsky MD; Yu EY;
    Clin Appl Thromb Hemost; 2017 Oct; 23(7):755-760. PubMed ID: 27637910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary prophylaxis of VTE in cancer outpatients.
    Imberti D; Benedetti R
    Thromb Res; 2016 Apr; 140 Suppl 1():S103-8. PubMed ID: 27067962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Khorana score for the prediction of venous thromboembolism in patients with pancreatic cancer.
    van Es N; Franke VF; Middeldorp S; Wilmink JW; Büller HR
    Thromb Res; 2017 Feb; 150():30-32. PubMed ID: 28002757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Application of Current Proposed Venous Thromboembolism Risk Assessment Model for Ambulatory Patients With Cancer.
    Abdel-Razeq H; Mansour A; Saadeh SS; Abu-Nasser M; Makoseh M; Salam M; Abufara A; Ismael Y; Ibrahim A; Khirfan G; Ibrahim M
    Clin Appl Thromb Hemost; 2018 Apr; 24(3):429-433. PubMed ID: 28183196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.